REPH Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (22 mar 2022 @ 05:00):

Stats
Dagens volum	137 536
Gjennomsnittsvolum	128 488
Markedsverdi	177.42M
EPS	$-0.0000600 ( 2023-03-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.04
ATR14	$0.0920 (4.40%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-02	Lake Ryan David	Sell	1 419	Common Stock
2023-12-15	Lake Ryan David	Sell	5 690	Common Stock
2023-11-30	Lake Ryan David	Sell	1 197	Common Stock
2023-10-31	Lake Ryan David	Sell	1 198	Common Stock
2023-09-30	Lake Ryan David	Sell	1 198	Common Stock

INSIDER POWER
94.69
Last 95 transactions
Buy: 16 300 004 \| Sell: 826 395

Volum Korrelasjon

Lang: -0.07 (neutral)

Kort: 0.64 (weak)

Signal:(67.783) Neutral

Recro Pharma Inc Korrelasjon

10 Mest positive korrelasjoner
CNDT	0.875
EGBN	0.874
ANNX	0.87
FEYE	0.863
CYXT	0.863
FNWB	0.861
DCOMP	0.858
FFWM	0.852
ATHA	0.846
BWBBP	0.843

10 Mest negative korrelasjoner
NRDS	-0.898
SGTX	-0.876
NVTS	-0.859
PESI	-0.851
MORF	-0.848
WVVI	-0.844
BTBD	-0.839
FTIV	-0.837
INOD	-0.836
AMRB	-0.835

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Recro Pharma Inc Korrelasjon - Valuta/Råvare

0.43
( neutral )

0.42
( neutral )

0.00
( neutral )

0.50
( neutral )

0.08
( neutral )

-0.50
( neutral )

Recro Pharma Inc Økonomi

Annual	2023
Omsetning:	$94.64M
Bruttogevinst:	$18.14M (19.17 %)
EPS:	$-0.000100

FY	2023
Omsetning:	$94.64M
Bruttogevinst:	$18.14M (19.17 %)
EPS:	$-0.000100

FY	2022
Omsetning:	$90.21M
Bruttogevinst:	$23.14M (25.65 %)
EPS:	$-0.340

FY	2021
Omsetning:	$75.36M
Bruttogevinst:	$19.82M (26.30 %)
EPS:	$-0.221

Financial Reports:

No articles found.

Recro Pharma Inc

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.